TY - JOUR
T1 - VPS35 regulates cell surface recycling and signaling of dopamine receptor D1
AU - Wang, Chen
AU - Niu, Mengxi
AU - Zhou, Zehua
AU - Zheng, Xiaoyuan
AU - Zhang, Lingzhi
AU - Tian, Ye
AU - Yu, Xiaojun
AU - Bu, Guojun
AU - Xu, Huaxi
AU - Ma, Qilin
AU - Zhang, Yun wu
N1 - Funding Information:
The authors thank Drs Wen-Cheng Xiong and Wanjin Hong for providing materials. This work was supported in part by grants from National Natural Science Foundation of China (nos. 81225008 , 81161120496 , 91332112 , 91332114 , and U1405222 ), National Institutes of Health ( R01AG021173 , R01AG038710 , R01AG044420 , and R01NS046673 ), Alzheimer's Association (to H.X. and Y.w.Z.), Fujian Provincial Department of Science and Technology (2015Y4008), and Xiamen University President Fund ( 20720150170 ).
Publisher Copyright:
© 2016 Elsevier Inc.
PY - 2016/10/1
Y1 - 2016/10/1
N2 - Vacuolar protein sorting 35 (VPS35) is a retromer complex component regulating membrane protein trafficking and retrieval. Mutations or dysfunction of VPS35 have been linked to Parkinson's disease (PD), which is pathologically characterized by the loss of dopamine neurons in brain substantia nigra region. Dopamine plays a key role in regulating various brain physiological functions by binding to its receptors and triggering their endocytosis and signaling pathways. However, it is unclear whether there is a link between VPS35 and dopamine signaling in PD. Herein, we found that VPS35 interacted with dopamine receptor D1 (DRD1). Notably, overexpression and downregulation of VPS35 increased and decreased steady-state cell surface levels of DRD1 and phosphorylation of cAMP-response element binding protein (CREB) and extracellular regulated protein kinases (ERK) that are important dopamine signaling effectors, respectively. In addition, overexpression of VPS35 promoted cell surface recycling of endocytic DRD1. Furthermore, downregulation of VPS35 abolished dopamine-induced CREB/ERK phosphorylation. More importantly, although the PD-associated VPS35 mutant VPS35 (D620N) still interacted with DRD1, its expression did not affect cell surface recycling of DRD1 and phosphorylation of CREB/ERK nor rescue the reduction of CREB/ERK phosphorylation caused by VPS35 downregulation. These results demonstrate that VPS35 regulates DRD1 trafficking and DRD1-mediated dopamine signaling pathway, and that the PD-associated VPS35 (D620N) mutant loses such functions, providing a novel molecular mechanism underlying PD pathogenesis.
AB - Vacuolar protein sorting 35 (VPS35) is a retromer complex component regulating membrane protein trafficking and retrieval. Mutations or dysfunction of VPS35 have been linked to Parkinson's disease (PD), which is pathologically characterized by the loss of dopamine neurons in brain substantia nigra region. Dopamine plays a key role in regulating various brain physiological functions by binding to its receptors and triggering their endocytosis and signaling pathways. However, it is unclear whether there is a link between VPS35 and dopamine signaling in PD. Herein, we found that VPS35 interacted with dopamine receptor D1 (DRD1). Notably, overexpression and downregulation of VPS35 increased and decreased steady-state cell surface levels of DRD1 and phosphorylation of cAMP-response element binding protein (CREB) and extracellular regulated protein kinases (ERK) that are important dopamine signaling effectors, respectively. In addition, overexpression of VPS35 promoted cell surface recycling of endocytic DRD1. Furthermore, downregulation of VPS35 abolished dopamine-induced CREB/ERK phosphorylation. More importantly, although the PD-associated VPS35 mutant VPS35 (D620N) still interacted with DRD1, its expression did not affect cell surface recycling of DRD1 and phosphorylation of CREB/ERK nor rescue the reduction of CREB/ERK phosphorylation caused by VPS35 downregulation. These results demonstrate that VPS35 regulates DRD1 trafficking and DRD1-mediated dopamine signaling pathway, and that the PD-associated VPS35 (D620N) mutant loses such functions, providing a novel molecular mechanism underlying PD pathogenesis.
KW - Dopamine
KW - Dopamine receptor D1
KW - Dopamine signaling
KW - Parkinson's disease
KW - Trafficking
KW - Vacuolar protein sorting 35
UR - http://www.scopus.com/inward/record.url?scp=84978204359&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84978204359&partnerID=8YFLogxK
U2 - 10.1016/j.neurobiolaging.2016.05.016
DO - 10.1016/j.neurobiolaging.2016.05.016
M3 - Article
C2 - 27460146
AN - SCOPUS:84978204359
SN - 0197-4580
VL - 46
SP - 22
EP - 31
JO - Neurobiology of Aging
JF - Neurobiology of Aging
ER -